O'Brien Federica F. 4
4 · TELA Bio, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
O'Brien Federica F.
Director
Transactions
- Award
Common Stock
[F1]2023-06-01+3,135→ 6,270 total - Award
Stock Option (Right to Buy)
[F2]2023-06-01+5,360→ 5,360 totalExercise: $10.34Exp: 2033-06-01→ Common Stock (5,360 underlying)
Footnotes (2)
- [F1]These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
Signature
/s/ Megan Smeykal, Attorney-in-fact|2023-06-02